Evidence for two candidate tumour suppressor loci on chromosome so in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines

British Journal of Cancer

Volumn 80, Issue 3-4, 1999, Pages 489-494

  Van Tilborg, A A G ^b   Groenfeld, L E ^b   Van Der Kwast, T H ^b   Zwarthoff, E C ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NONE

Author keywords

Bladder cancer; Chromosome 9; Deletion mapping; Loss of heterozygosity; Transitional cell carcinoma; Tumour suppressor genes

Indexed keywords

ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CHROMOSOME 9P; CHROMOSOME 9Q; CONTROLLED STUDY; GENE DELETION; GENE LOCUS; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0006181622     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690383     Document Type: Article

References (34)

1. Ah-Sec KW, Cooke TG, Pickford IR, Soutar D and Balmain A (1994) An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 54: 1617-1621
2. INK4A/CDKN2/ MTSI gene in primary urothelial cancers. Jpn J Cancer Res 88: 1078-1086
3. Brewster SF, Gingell JC, Browne S and Brown KW (1994) Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder. Br J Cancer 70: 697-700
4. Cairns P (1995) Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 11: 210-212
5. Cairns P, Shaw ME and Knowles MA (1993) Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Oncogene 8: 1083-1085
6. Cairns P, Tokino K, Eby Y and Sidransky D (1995) Localization of tumour suppressor loci on chromosome 9 in primary human renal cell carcinomas. Cancer Res 55: 224-227
7. Chang WYH (1995) Novel suppressor loci on chromosome 14q in primary bladder cancer. Cancer Res 55: 3246-3249
8. Corcoran MM, Rasool O, Liu Y, Iyengar A, Grander D, Ibbotson RE, Merup M, Wu X, Brodyansky V, Gardiner AC, Juliusson G, Chapman RM, Ivanova G, Tiller M, Gahrton G, Yankovsky N, Zabarovsky E, Oscier DG and Einhorn S (1998) Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia. Blood 91: 1382-1390
9. Devlin J, Keen AJ and Knowles MA (1994) Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2 cM of IFN-A. Oncogene 9: 2757-2760
10. Elder PA, Bell SM and Knowles MA (1994) Deletion of two regions on chromosome 4 in bladder carcinoma: definition of a critical 750 kb region at 4p16.3. Oncogene 9: 3433-3436
11. Habuchi T, Devlin J, Elder PA and Knowles MA (1995) Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci. Oncogene 11: 1671-1674
12. Habuchi T, Yoshida O and Knowles MA (1997) A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC. Hum Mol Genet 6: 913-919
13. Habuchi T, Luscombe M, Elder PA and Knowles MA (1998) Structure and methylation-based silencing of a gene (DBCCRI) within a candidate bladder cancer tumor suppressor region at 9q32-33. Genomics 48: 277-288
14. Jacoby LB, MacCollin M, Louis DN, Mohney T, Rubio MP, Pulaski K, Trofatter JA, Kley N, Seizinger B, Ramesh V and Gusella JF (1994) Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3: 413-419
15. Keen AJ and Knowles MA (1994) Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Oncogene 9: 2083-2088
16. Knowles MA, Shaw ME and Proctor AJ (1993) Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene 8: 1357-1364
17. Kohno T, Kawanishi M, Matsuda S, Ichikawa H, Takada M, Ohki M, Yamamoto T and Yokota J (1998) Homozygous deletion and frequent allelic loss of the 21q11.1-q21.1 region including the ANA gene in human lung carcinoma. Genes Chromosomes Cancer 21: 236-243
18. Linnenbach AJ, Pressler LB, Seng BA, Kimmel BS, Tomaszewski JW and Malkowicz SB (1993) Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay. Hum Mol Genet 2: 1407-1411
19. Merlo A, Gabrielson E, Mabry M, Vollmer R, Baylin SB and Sidransky D (1994) Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res 54: 2322-2326
20. Miura K, Suzuki K, Tokino T, Isomura M, Inazawa J, Matsuno S and Nakamura Y (1996) Detailed deletion mapping in squamous cell carcinoma of the esophagus narrows a region containing a putative tumor suppressor gene to about 200 kilobases on distal chromosome 9q. Cancer Res 56: 1629-1634
21. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756
22. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE and Cordon-Cardo C (1994) Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res 54: 2848-2851
23. Polascik TJ, Cairns P, Chang WYH, Schoenberg MP and Sidransky D (1995) Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. Cancer Res 55: 5396-5399
24. Ruppert JM, Tokino K and Sidransky D (1993) Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res 53: 5093-5095
25. Sambrook J, Fritsch E and Maniatis T (1989) Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Laboratory: New York
26. Shanley SM, Dawkins H, Wainwright BJ, Wicking C, Heenan P, Eldon M, Searle J and Chenevix-Trench G (1995) Fine deletion mapping on the long arm of chromosome 9 in sporadic and familial basal cell carcinomas. Hum Mol Genet 4: 129-133
27. Shipman R, Schrami P, Colombi M, Raefle G and Ludwig CU (1993) Loss of heterozygosity on chromosome 11p13 in primary bladder carcinoma. Hum Genet, 91: 455-458
28. Shultz DC, Vanderveer L, Buetow KH, Boente MP, Ozols RF, Hamilto TC and Godwin AK (1995) Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. Cancer Res 55: 2150-2157.
29. Simoneau AR, Spruck CH Jr, Gonzalez-Zulueta M, Gonzalgo ML, Chan MF, Tsai YC, Dean M, Steven K, Horn T and Jones PA (1996) Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GASI and PTC mutations. Cancer Res 56: 5039-5043
30. Southgate J, Proffitt J, Roberts P, Smith B and Selby P (1995) Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines. Br J Cancer 72: 1214-1218
31. Takle LA and Knowles MA (1996) Deletion mapping implicates two tumour suppressor genes on chromosome 8p in the development of bladder cancer. Oncogene 12: 1083-1087
32. Tamimi Y, Bringuier PP, Smit F, van Bokhoven A, Abbas A, Debruyne FM and Schalken JA (1996) Homozygous deletions of p16(INK4) occur frequently in bilharziasis-associated bladder cancer. Int J Cancer 68: 183-187
33. Van Tilborg AAG, Hekman ACP, Vissers KJ, van der Kwast TH and Zwarthoff EC (1998) Loss of heterozygosity on chromosome 9 and loss of chromosome 9 copy number are separate events in the pathogenesis of transitional cell carcinoma of the bladder. Int J Cancer 75: 9-14
34. Williamson MP, Elder PA, Shaw ME, Devlin J and Knowles MA (1995) p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum Mol Genet 4: 1569-1577